Sarah Tang

Sarah Tang has work experience as a Scientist I, Biology at Neomorph, Inc. since August 2021. Prior to that, they were a PhD Candidate at Memorial Sloan Kettering Cancer Center from July 2015 to July 2021. In 2020, they worked at Weill Cornell Medicine & BioVenture eLab in the role of Accelerating Bio Venture Innovation from September to December. In 2019, they completed a Drug Development Course: From Molecule to Prescription at Weill Cornell Graduate School & Tri-Institutional Therapeutics Discovery Institute from January to May.

Sarah Tang completed their Bachelor of Science degree in Microbiology and Immunology at UC Irvine from 2011 to 2015. Sarah then pursued further education at the Gerstner Sloan Kettering Graduate School of Biomedical Sciences at Memorial Sloan Kettering Cancer Center from 2015 to 2021, where they obtained their Doctor of Philosophy degree in Cancer Biology.